Drukała Zbigniew, Ciborowska-Zielińska Beata, Kubrak Jadwiga, Rogowska Danuta
Department of Radiotherapy, West Pomeranian Oncology Centre, Szczecin, Poland.
Pomeranian Medical University, Szczecin, Poland.
Rep Pract Oncol Radiother. 2010 May 20;15(3):75-7. doi: 10.1016/j.rpor.2010.03.002. eCollection 2010.
Endometriosis occurring in surgical scars is a well-described entity. Malignant transformation of endometriosis is a rare event, with most cases belonging to adenocarcinoma. The initial surgical treatment is a method of choice. Due to lack of therapeutic recommendations, adjuvant therapy and recurrence management are a great challenge for oncologists.
The aim of this paper was to present a long-term survival as the outcome of multimodal therapy in the patient with recurrent adenocarcinoma arising from Caesarean section scar endometriosis.
We present the case of a woman with recurrent adenocarcinoma arising from Caesarean section scar endometriosis. The disease was first diagnosed in September 1997 at age 43. The patient underwent abdominal hysterectomy with tumour excision. Due to a local recurrence after 4 years, tumour excision with abdominal wall repair using a plastic mesh, regional lymphadenectomy, bilateral salpingo-ovariectomy and adjuvant radiotherapy for the pelvic region with local boost were performed; in addition hormontherapy with medroxyprogesterone was started. Because of a recurrent pelvic tumour, chemotherapy, further local palliative radiotherapy and brachytherapy were administered. Subsequently distant metastases in bilateral axillary lymph nodes were diagnosed and palliative radiotherapy was performed. The patient died of morbus neoplasmaticus generalisatus in September 2008. The follow-up period had been 132 months.
This paper is, to our knowledge, the only report in literature that presents a long-term survival as the outcome of multimodal therapy in the patient with this rare diagnosis. Further reports of new cases can help establish optimal treatment guidelines.
手术瘢痕内异症是一种已被充分描述的病症。内异症的恶变是罕见事件,大多数病例为腺癌。初始手术治疗是首选方法。由于缺乏治疗建议,辅助治疗和复发管理对肿瘤学家而言是巨大挑战。
本文旨在呈现多模式治疗对剖宫产瘢痕内异症复发腺癌患者的长期生存结果。
我们报告一例剖宫产瘢痕内异症复发腺癌的女性患者。该疾病于1997年9月首次诊断,患者43岁。患者接受了经腹子宫切除术及肿瘤切除术。4年后出现局部复发,遂行肿瘤切除、腹壁用整形网片修补、区域淋巴结清扫、双侧输卵管卵巢切除术,并对盆腔进行局部加量辅助放疗;此外,开始使用甲羟孕酮进行激素治疗。因盆腔肿瘤复发,给予化疗、进一步的局部姑息性放疗及近距离放疗。随后诊断出双侧腋窝淋巴结远处转移,并进行了姑息性放疗。患者于2008年9月死于全身肿瘤病。随访期为132个月。
据我们所知,本文是文献中唯一一篇报道多模式治疗对该罕见诊断患者长期生存结果的报告。更多新病例报告有助于制定最佳治疗指南。